Actively Recruiting
A Study on the Preference of Risperidone Dosage Forms
Led by Shanghai Mental Health Center · Updated on 2024-10-24
1000
Participants Needed
1
Research Sites
23 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aimed to understand patients' needs and preferences for antipsychotic dosage forms.
CONDITIONS
Official Title
A Study on the Preference of Risperidone Dosage Forms
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with schizophrenia, bipolar disorder, autism spectrum disorder, mental retardation, or conduct disorder
- Primary caregivers of patients with these conditions
- Voluntary participation in the study
You will not qualify if you...
- Difficulty reading and understanding Chinese
- Refusal to participate in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Shanghai Mental Health Center
Shanghai, Shanghai Municipality, China, 200030
Actively Recruiting
Research Team
L
Lan Luo, Doctor of Medicine
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here